The DOI matches its Crossref record; 73 of the 73 references it cites were found in a registry or an index.
Development of 2A peptide-based strategies in the design of multicistronic vectors
Abstract
As science progresses in its understanding of diseases and their treatment, advances have been made in the biotechnology used in disease therapy. Most gene therapy approaches utilise viral vectors to deliver genes of interest. However, multiple proteins are often involved in disease processes and there is often a need to efficiently deliver more than one gene. Researchers have employed several strategies to accomplish this goal. When designing vectors to express multiple genes, there are several factors that need to be taken into account, including cell type, the activity of the protein of interest and subcellular protein localisation. In most cases, it is ideal for each protein to be expressed at comparable levels, a leading issue with traditional strategies for multigene expression. This review describes some of the techniques that have been used to express multiple genes, and will focus on the use of 2A peptides or 2A peptide-like sequences in the design of multicistronic vectors that may alleviate some of these issues.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pelletier, J., & Sonenberg, N. (1988) · Nature · doi:10.1038/334320a0 · Cited by 1,934
Jang, S. K., Kräusslich, H. G., Nicklin, M. J., Duke, G. M., Palmenberg, A. C., & Wimmer, E. (1988) · Journal of Virology · doi:10.1128/jvi.62.8.2636-2643.1988 · Cited by 1,362
Viral vectors for gene therapy: the art of turning infectious agents into vehicles of therapeutics
Kay, M. A., Glorioso, J. C., & Naldini, L. (2001) · Nature Medicine · doi:10.1038/83324 · Cited by 1,342
Szymczak, A. L., Workman, C. J., Wang, Y., Vignali, K. M., Dilioglou, S., Vanin, E. F., & Vignali, D. A. A. (2004) · Nature Biotechnology · doi:10.1038/nbt957 · Cited by 1,059
Self-citationInternal ribosome entry sites in eukaryotic mRNA molecules
Hellen, C. U. T., & Sarnow, P. (2001) · Genes & Development · doi:10.1101/gad.891101 · Cited by 986
Donnelly, M. L. L., Luke, G., Mehrotra, A., Li, X., Hughes, L. E., Gani, D., & Ryan, M. D. (2001) · Journal of General Virology · doi:10.1099/0022-1317-82-5-1013 · Cited by 798
Mizuguchi, H., Xu, Z., Ishii-Watabe, A., Uchida, E., & Hayakawa, T. (2000) · Molecular Therapy · doi:10.1006/mthe.2000.0050 · Cited by 559
Donnelly, M. L. L., Hughes, L. E., Luke, G., Mendoza, H., ten Dam, E., Gani, D., & Ryan, M. D. (2001) · Journal of General Virology · doi:10.1099/0022-1317-82-5-1027 · Cited by 534
Ryan, M. D., King, A. M. Q., & Thomas, G. P. (1991) · Journal of General Virology · doi:10.1099/0022-1317-72-11-2727 · Cited by 477
Viral Vectors for Gene Transfer: A Review of Their Use in the Treatment of Human Diseases
Walther, W., & Stein, U. (2000) · Drugs · doi:10.2165/00003495-200060020-00002 · Cited by 442
Jang, S. K., Davies, M. V., Kaufman, R. J., & Wimmer, E. (1989) · Journal of Virology · doi:10.1128/jvi.63.4.1651-1660.1989 · Cited by 413
Foot-and-mouth disease virus 2A oligopeptide mediated cleavage of an artificial polyprotein.
Ryan, M. D., & Drew, J. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06337.x · Cited by 378
Cullen, B. R., Lomedico, P. T., & Ju, G. (1984) · Nature · doi:10.1038/307241a0 · Cited by 355
The T Cell Antigen Receptor: Insights into Organelle Biology
Klausner, R. D., Lippincott-Schwartz, J., & Bonifacino, J. S. (1990) · Annual Review of Cell Biology · doi:10.1146/annurev.cb.06.110190.002155 · Cited by 354
Ghattas, I. R., Sanes, J. R., & Majors, J. E. (1991) · Molecular and Cellular Biology · doi:10.1128/mcb.11.12.5848 · Cited by 349
Unique features of internal initiation of hepatitis C virus RNA translation.
Reynolds, J. E., Kaminski, A., Kettinen, H. J., Grace, K., Clarke, B. E., Carroll, A. R., Rowlands, D. J., & Jackson, R. J. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb00289.x · Cited by 338
Immunotherapy through TCR gene transfer
Kessels, H. W. H. G., Wolkers, M. C., van den Boom, M. D., van den Valk, M. A., & Schumacher, T. N. M. (2001) · Nature Immunology · doi:10.1038/ni1001-957 · Cited by 279
Tahara, H., Zitvogel, L., Storkus, W. J., Zeh, H. J., McKinney, T. G., Schreiber, R. D., Gubler, U., Robbins, P. D., & Lotze, M. T. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.154.12.6466 · Cited by 271
Kaufman, R. J., Davies, M. V., Wasley, L. C., & Michnick, D. (1991) · Nucleic Acids Research · doi:10.1093/nar/19.16.4485 · Cited by 261
Irresistible IRES: Attracting the translation machinery to internal ribosome entry sites
Vagner, S., Galy, B., & Pyronnet, S. (2001) · EMBO reports · doi:10.1093/embo-reports/kve208 · Cited by 261
Chappell, S. A., Edelman, G. M., & Mauro, V. P. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.4.1536 · Cited by 241
Borman, A. M., Le Mercier, P., Girard, M., & Kean, K. M. (1997) · Nucleic Acids Research · doi:10.1093/nar/25.5.925 · Cited by 238
Self-contained, tetracycline-regulated retroviral vector system for gene delivery to mammalian cells
Paulus, W., Baur, I., Boyce, F. M., Breakefield, X. O., & Reeves, S. A. (1996) · Journal of Virology · doi:10.1128/jvi.70.1.62-67.1996 · Cited by 207
Morgan, R. A., Couture, L., Elroy-Stein, O., Ragheb, J., Moss, B., & French Anderson, W. (1992) · Nucleic Acids Research · doi:10.1093/nar/20.6.1293 · Cited by 204
Targeting gene therapy to cancer: a review.
Dachs, G. U., Dougherty, G. J., Stratford, I. J., et al. (1997) · PubMed · Cited by 187
Hennecke, M. (2001) · Nucleic Acids Research · doi:10.1093/nar/29.16.3327 · Cited by 184
Fussenegger, M. (2001) · Biotechnology Progress · doi:10.1021/bp000129c · Cited by 174
Dicistronic transcription units for gene expression in mammalian cells
Dirks, W., Wirth, M., & Hauser, H. (1993) · Gene · doi:10.1016/0378-1119(93)90569-o · Cited by 173
de Felipe, P., Hughes, L. E., Ryan, M. D., & Brown, J. D. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211644200 · Cited by 167
High Mutation Rate of a Spleen Necrosis Virus-Based Retrovirus Vector
Dougherty, J. P., & Temin, H. M. (1986) · Molecular and Cellular Biology · doi:10.1128/mcb.6.12.4387 · Cited by 154
Krisky, D., Marconi, P., Oligino, T., et al. (1998) · Gene Therapy · doi:10.1038/sj.gt.3300755 · Cited by 153
Borman, A. M., Bailly, J., Girard, M. P., & Kean, K. M. (1995) · Nucleic Acids Research · doi:10.1093/nar/23.18.3656 · Cited by 152
Palmer, T. D., Hock, R. A., Osborne, W. R. A., & Miller, A. D. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.4.1055 · Cited by 143
Zitvogel, L., Tahara, H., Cai, Q., Storkus, W. J., Müller, G., Wolf, S. F., Gately, M. K., Robbins, P. D., & Lotze, M. T. (1994) · Human Gene Therapy · doi:10.1089/hum.1994.5.12-1493 · Cited by 131
Factors affecting long-term stability of Moloney murine leukemia virus-based vectors
Xu, L., Yee, J. K., Wolff, J. A., & Friedmann, T. (1989) · Virology · doi:10.1016/0042-6822(89)90600-4 · Cited by 128
Generation of Mammalian Cells Stably Expressing Multiple Genes at Predetermined Levels
Liu, X., Constantinescu, S. N., Sun, Y., Bogan, J. S., Hirsch, D., Weinberg, R. A., & Lodish, H. F. (2000) · Analytical Biochemistry · doi:10.1006/abio.2000.4478 · Cited by 128
Arnold, P. Y., Gruta, N. L. L., Miller, T. J., Vignali, K. M., Adams, P. S., Woodland, D. L., & Vignali, D. A. A. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.2.739 · Cited by 121
Self-citationDevelopment of Multigene and Regulated Lentivirus Vectors
Reiser, J., Lai, Z., Zhang, X., & Brady, R. O. (2000) · Journal of Virology · doi:10.1128/jvi.74.22.10589-10599.2000 · Cited by 121
Roberts, L. O., SEAMONS, R. A., & Belsham, G. J. (1998) · RNA · doi:10.1017/s1355838298971989 · Cited by 115
Furler, S., Paterna, J. C., Weibel, M., & Büeler, H. (2001) · Gene Therapy · doi:10.1038/sj.gt.3301469 · Cited by 115
Kozak, M. (2003) · Gene · doi:10.1016/s0378-1119(03)00774-1 · Cited by 112
Skipping the co-expression problem: the new 2A "CHYSEL" technology
de Felipe, P. (2004) · Genetic Vaccines and Therapy · doi:10.1186/1479-0556-2-13 · Cited by 110
Comparison of promoter suppression in avian and murine retrovirus vectors
Emerman, M., & Temin, H. M. (1986) · Nucleic Acids Research · doi:10.1093/nar/14.23.9381 · Cited by 93
de Felipe, P., Martín, V., Cortés, M. L., Ryan, M. D., & Izquierdo, M. (1999) · Gene Therapy · doi:10.1038/sj.gt.3300811 · Cited by 93
Walther, W., & Stein, U. (1996) · Journal of Molecular Medicine · doi:10.1007/bf00210632 · Cited by 90
Factors Affecting Retroviral Vector Function and Structural Integrity
McLachlin, J. R., Mittereder, N., Daucher, M. B., et al. (1993) · Virology · doi:10.1006/viro.1993.1340 · Cited by 85
Sugimoto, Y., Aksentijevich, I., Murray, G. J., Brady, R. O., Pastan, I. H., & Gottesman, M. M. (1995) · Human Gene Therapy · doi:10.1089/hum.1995.6.7-905 · Cited by 79
cis-Acting Regulatory Elements within gag Genes of Avian Retroviruses
Arrigo, S. J., Yun, M., & BEEMON, K. L. (1987) · Molecular and Cellular Biology · doi:10.1128/mcb.7.1.388-397.1987 · Cited by 77
Gallardo, H., Tan, C. W., & Sadelain, M. (1997) · Gene Therapy · doi:10.1038/sj.gt.3300506 · Cited by 69
López‐Lastra, M., Gabus, C., & Darlix, J. (1997) · Human Gene Therapy · doi:10.1089/hum.1997.8.16-1855 · Cited by 68
Douin‐Echinard, V., Bornes, S., Créancier, L., Rochaix, P., Favre, G., Prats, A., & Couderc, B. C. (2004) · BMC Biotechnology · doi:10.1186/1472-6750-4-16 · Cited by 67
Klump, H., Schiedlmeier, B., Vogt, B., Ryan, M. D., Ostertag, W., & Baum, C. (2001) · Gene Therapy · doi:10.1038/sj.gt.3301447 · Cited by 67
de Felipe, P. (2002) · Current Gene Therapy · doi:10.2174/1566523023347742 · Cited by 60
Transcriptional control: an essential component of cancer gene therapy strategies?
Harrington, K. J., Linardakis, E., & Vile, R. G. (2000) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00093-4 · Cited by 59
Owens, G. C., Chappell, S. A., Mauro, V. P., & Edelman, G. M. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.4.1471 · Cited by 53
Picornaviruses break the rules
Jackson, R. J. (1988) · Nature · doi:10.1038/334292a0 · Cited by 53
Expression of complete chicken thymidine kinase gene inserted in a retrovirus vector.
Bandyopadhyay, P. K., & Temin, H. M. (1984) · Molecular and Cellular Biology · doi:10.1128/mcb.4.4.749 · Cited by 46
Overell, R. W., Weisser, K. E., & Cosman, D. J. (1988) · Molecular and Cellular Biology · doi:10.1128/mcb.8.4.1803 · Cited by 45
Berlioz‐Torrent, C., Torrent, C., & Darlix, J. (1995) · Journal of Virology · doi:10.1128/jvi.69.10.6400-6407.1995 · Cited by 44
Paquin, A., Jaalouk, D. E., & Galipeau, J. (2001) · Human Gene Therapy · doi:10.1089/104303401450924 · Cited by 43
Bouayadi, K., Hoffmann, J., Fons, P., Tiraby, M., Reynes, J.-P., & Cazaux, C. (1997) · PubMed · Cited by 35
Shaw-Jackson, C., & Michiels, T. (1999) · Journal of Virology · doi:10.1128/jvi.73.4.2729-2738.1999 · Cited by 34
Fusagene vectors: a novel strategy for the expression of multiple genes from a single cistron
Gäken, J. A., Jiang, J., Daniel, K., van Berkel, E., Hughes, C., Kuiper, M., Darling, D., Tavassoli, M., Galea‐Lauri, J., Ford, K. G., et al. (2000) · Gene Therapy · doi:10.1038/sj.gt.3301341 · Cited by 33
Nanbru, C., Prats, A., Droogmans, L., Defrance, P., Huez, G. A., & Kruys, V. (2001) · Oncogene · doi:10.1038/sj.onc.1204548 · Cited by 33
Wen, X., Mandelbaum, S., Li, Z. H., Hitt, M., Graham, F. L., Hawley, T. S., Hawley, R. G., & Stewart, A. K. (2001) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700321 · Cited by 33
Boerkoel, C. F., & Kung, H. (1992) · Journal of Virology · doi:10.1128/jvi.66.8.4814-4823.1992 · Cited by 30
Flaßhove, M., Bardenheuer, W., Schneider, A., Hirsch, G. N., Bach, P., Bury, C., Moritz, T., Seeber, S., & Opalka, B. (2000) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/pl00008487 · Cited by 27
Wang, S., Beattie, G. M., Hayek, A., & Levine, F. (1996) · Gene · doi:10.1016/s0378-1119(96)00536-7 · Cited by 26
Harries, M., Phillipps, N., Anderson, R. W., Prentice, G., & Collins, M. K. (2000) · The Journal of Gene Medicine · Cited by 23
General Strategy for Constructing Large HSV-1 Plasmid Vectors that Co-Express Multiple Genes
Wang, X., Zhang, G., Sun, M., & Geller, A. I. (2001) · BioTechniques · doi:10.2144/01311dd05 · Cited by 18
Fan, L., Owen, J. S., & Dickson, G. (1999) · Atherosclerosis · doi:10.1016/s0021-9150(99)00191-4 · Cited by 16
Veelken, H., Ré, D., Kulmburg, P., Rosenthal, F. M., Mackensen, A., Mertelsmann, R. H., & Lindemann, A. (1996) · Human Gene Therapy · doi:10.1089/hum.1996.7.15-1827 · Cited by 15
Douin‐Echinard, V. (2003) · International Immunology · doi:10.1093/intimm/dxg038 · Cited by 11
Cited by
The inhibitory cytokine IL-35 contributes to regulatory T-cell function
Collison, L. W., Workman, C. J., Kuo, T. T., Boyd, K., Wang, Y., Vignali, K. M., Cross, R., Sehy, D., Blumberg, R. S., & Vignali, D. A. A. (2007) · Nature · doi:10.1038/nature06306 · Cited by 2,066
Self-citationKim, J. H., Lee, S.-R., Li, L.-H., Park, H.-J., Park, J.-H., Lee, K. Y., Kim, M.-K., Shin, B. A., & Choi, S.-Y. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018556 · Cited by 1,338
Systematic comparison of 2A peptides for cloning multi-genes in a polycistronic vector
Liu, Z., Chen, O., Wall, J. B. J., Zheng, M., Zhou, Y., Wang, L., Ruth Vaseghi, H., Qian, L., & Liu, J. (2017) · Scientific Reports · doi:10.1038/s41598-017-02460-2 · Cited by 745
Chapman, H. A., Li, X., Alexander, J. P., Brumwell, A., Lorizio, W., Tan, K., Sonnenberg, A., Wei, Y., & Vu, T. H. (2011) · Journal of Clinical Investigation · doi:10.1172/jci57673 · Cited by 406
E unum pluribus: multiple proteins from a self-processing polyprotein
de Felipe, P., Luke, G. A., Hughes, L. E., Gani, D., Halpin, C., & Ryan, M. D. (2006) · Trends in Biotechnology · doi:10.1016/j.tibtech.2005.12.006 · Cited by 358
Metadata
- Authors
- Szymczak, A. L., & Vignali, D. A.
- Venue
- Expert Opinion on Biological Therapy
- Publisher
- Informa UK Limited
- Published
- 2005-05
- Volume
- 5
- Issue
- 5
- Pages
- 627-638
- ISSN
- 1471-2598 (ISSN-L)
- 1744-7682
- OpenAlex
- W1982048287
- Cited by
- 283
- References
- 73
- FWCI
- 2.18
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.